GENOVIS AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30 SEK | -2.91% |
|
-15.49% | -42.31% |
| 05-15 | Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-14 | Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Diagnostic & Testing Substances
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 186M | ||||||
| 11.48B | ||||||
| 7.64B | ||||||
| 5.49B | - | - | ||||
| 3.86B | ||||||
| 2.61B | - | - | - | - | - |
- Stock Market
- Equities
- GENO Stock
- Charts Genovis AB
- Sector Chart
